Search

Displaying results 8341 - 8350 of 10000 in total
  1. Drug

    Dotarizine

    go.drugbank.com/drugs/DB06446
    Experimental

    Categories: Calcium-Regulating Hormones and Agents
  2. Drug

    Foliglurax

    go.drugbank.com/drugs/DB15292
    Investigational

    Study in Healthy Male and Female Subjects). … Foliglurax is under investigation in clinical trial NCT02639221 (A Phase I, Double Blind, Placebo Controlled, First in Human, Single and Multiple Ascending Oral Dose, Safety, Tolerability and Pharmacokinetic

  3. Drug

    1-Dodecanol

    go.drugbank.com/drugs/DB06894
    Experimental

    1-Dodecanol is a saturated 12-carbon fatty alcohol obtained from coconut oil fatty acids. It has a floral odor and is used in detergents, lubricating oils, and pharmaceuticals. … (From McGraw-Hill Dictionary of Scientific and Technical Terms, 5th ed)

  4. Drug

    Verinurad

    go.drugbank.com/drugs/DB11873
    Investigational

    Verinurad has been used in trials studying the basic science and treatment of Gout, Gout and Hyperuricemia, and Gout and Asymptomatic Hyperuricemia.

  5. Indication

    Hepatocellular Carcinoma

    go.drugbank.com/conditions/DBCOND0030090
    Drugs: Cabozantinib · Capecitabine · Hyaluronidase (human recombinant) · Ipilimumab · Nivolumab · Pembrolizumab +2 more
    Synonyms: CA - Liver cancer, (Liver carcinoma) or (Ca: [liver/biliary system] or [biliary system])
  6. Drug

    Nefiracetam

    go.drugbank.com/drugs/DB13082
    Investigational

    Nefiracetam has been used in trials studying the treatment of Alzheimer's Disease.

    Categories: Compounds used in a research, industrial, or household setting
  7. Drug

    PLX51107

    go.drugbank.com/drugs/DB17543
    Investigational

    [A257246,A257251] PLX51107 is under investigation in clinical trial NCT04022785 (PLX51107 and Azacitidine in Treating Patients With Acute Myeloid Leukemia or Myelodysplastic Syndrome). … PLX51107 is a potent and selective inhibitor of the bromodomain and extraterminal (BET) protein family.

  8. Drug

    Tesaglitazar

    go.drugbank.com/drugs/DB06536
    Investigational

    Tesaglitazar is a proposed treatment for type 2 diabetes and has completed several phase III clinical trials, however in May 2006 AstraZeneca announced that they had discontinued further development. … Tesaglitazar is a dual peroxisome proliferator-activated receptor alpha/gamma agonist which improves apolipoprotein levels in non-diabetic subjects with insulin resistance.

  9. Drug

    Acrizanib

    go.drugbank.com/drugs/DB16081
    Investigational

    Acrizanib is under investigation in clinical trial NCT02355028 (LHA510 Proof-of-concept Study as a Maintenance Therapy for Patients With Wet Age-related Macular Degeneration).

    Categories: Compounds used in a research, industrial, or household setting
  10. Drug

    (1H-indol-3-yl)-(2-mercapto-ethoxyimino)-acetic acid

    go.drugbank.com/drugs/DB03455
    Experimental

    These are compounds containing an acetic acid (or a derivative) linked to the C3 carbon atom of an indole. (1H-indol-3-yl)-(2-mercapto-ethoxyimino)-acetic acid is known to target interleukin-2. … (1H-indol-3-yl)-(2-mercapto-ethoxyimino)-acetic acid is a solid. This compound belongs to the indole-3-acetic acid derivatives.